Jacob Vincent Micallef Volitionrx LTD (VNRX) insider trading activity

Jacob Vincent Micallef is Chief Scientific Officer of VOLITIONRX LTD. Currently has a direct ownership of 393,089 shares of VNRX, which is worth approximately $129,719. The most recent transaction as insider was on Oct 04, 2025, when has been sold 5,850 shares (Common Stock) at a price of $0.65 per share, resulting in proceeds of $3,802. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 393K

2.82% 3M change

12.1% 12M change

Total Value Held $129,719

Jacob Vincent Micallef Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 04 2025	SELL Payment of exercise price or tax liability	$3,802 $0.65 p/Share	5,850 Reduced 1.47%	393,089 Common Stock
Sep 28 2025	SELL Payment of exercise price or tax liability	$3,340 $0.6 p/Share	5,568 Reduced 1.38%	398,939 Common Stock
Jun 01 2025	SELL Payment of exercise price or tax liability	$10,763 $0.5 p/Share	21,526 Reduced 5.05%	404,507 Common Stock
May 19 2025	BUY Open market or private purchase	$21,500 $0.43 p/Share	50,000 Added 10.5%	426,033 Common Stock
May 01 2025	SELL Payment of exercise price or tax liability	$8,976 $0.49 p/Share	18,319 Reduced 4.65%	376,033 Common Stock
Dec 09 2024	BUY Open market or private purchase	$24,903 $0.57 p/Share	43,691 Added 9.97%	394,352 Common Stock
Oct 04 2024	SELL Payment of exercise price or tax liability	$4,576 $0.88 p/Share	5,200 Reduced 1.46%	350,661 Common Stock
Sep 28 2024	SELL Payment of exercise price or tax liability	$2,871 $0.58 p/Share	4,950 Reduced 1.37%	355,861 Common Stock
Sep 01 2024	BUY Grant, award, or other acquisition	-	47,837 Added 11.71%	360,811 Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	13,750 Added 4.21%	312,974 Common Stock
Jun 01 2024	BUY Grant, award, or other acquisition	-	40,709 Added 11.98%	299,224 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	23,375 Added 8.29%	258,515 Common Stock
Aug 25 2023	BUY Open market or private purchase	$24,800 $1.24 p/Share	20,000 Added 7.84%	235,140 Common Stock
Aug 03 2023	SELL Payment of exercise price or tax liability	$7,055 $1.3 p/Share	5,427 Reduced 2.46%	215,140 Common Stock
Jul 05 2023	BUY Grant, award, or other acquisition	-	17,550 Added 7.37%	220,567 Common Stock
Jan 12 2023	BUY Grant, award, or other acquisition	-	14,625 Added 6.72%	203,017 Common Stock
Dec 19 2022	BUY Open market or private purchase	$57,499 $2.3 p/Share	25,000 Added 11.72%	188,392 Common Stock
Dec 16 2022	BUY Open market or private purchase	$14,384 $1.96 p/Share	7,339 Added 4.3%	163,392 Common Stock
Oct 13 2022	BUY Grant, award, or other acquisition	-	6,825 Added 4.19%	156,053 Common Stock
Aug 26 2022	BUY Open market or private purchase	$50,460 $1.74 p/Share	29,000 Added 16.27%	149,228 Common Stock
Aug 03 2022	SELL Payment of exercise price or tax liability	$9,505 $1.97 p/Share	4,825 Reduced 3.86%	120,228 Common Stock
Jun 23 2022	BUY Grant, award, or other acquisition	-	15,682 Added 11.14%	125,053 Common Stock
Apr 07 2022	BUY Grant, award, or other acquisition	-	8,443 Added 7.17%	109,371 Common Stock

JVM

Jacob Vincent Micallef

Chief Scientific Officer

Henderson, NV

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Value

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VOLITIONRX LTD

Track Activities on VNRX

Account